Availability of new medicines in Europe in 2022, by country

Number of medicines approved by the EMA available to patients in Europe as of 2022, by country

Exclusive Premium statistic

You need a Statista Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Statista Accounts

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

April 2022



Survey time period

as of January 1, 2022

Supplementary notes

160 products were approved by the European Medicines Agency between 2017 and 2020.
In most countries availability equates to granting of access to the reimbursement list, except in DK, FI, NO, SE some hospital products are not covered by the general reimbursement scheme.
* Country did not complete a full dataset and therefore availability may be unrepresentative.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical trends in Europe "

Statistics on Pharmaceutical trends in Europe



Leading companies




R&D / Clinical trials / Approvals


Self-medication market


Further related statistics

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.